Dexcom Inc
NASDAQ:DXCM
EV/GP
Enterprise Value to Gross Profit
Market Cap | EV/GP | ||||
---|---|---|---|---|---|
US |
Dexcom Inc
NASDAQ:DXCM
|
49.1B USD | 21.2 | ||
US |
Abbott Laboratories
NYSE:ABT
|
183.8B USD | 8.5 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
131.5B USD | 26 | ||
US |
Stryker Corp
NYSE:SYK
|
127.9B USD | 10.4 | ||
IE |
Medtronic PLC
NYSE:MDT
|
106.7B USD | 5.8 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
105.3B USD | 11.4 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
67.8B USD | 10 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
58.1B EUR | 8.8 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
50.9B USD | 10.8 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 15.7 | ||
US |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
40.9B USD | 18.9 |
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.